Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Folic acid
Colonis Pharma Ltd
B03BB01
Folic acid
1mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010200; GTIN: 5060380960368
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. ■ Keep this leaflet. You may need to read it again. ■ If you have any further questions, ask your doctor or pharmacist. ■ This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. ■ If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Folic acid oral solution is and what it is used for 2. What you need to know before you take Folic acid oral solution 3. How to take Folic acid oral solution 4. Possible side effects 5. How to store Folic acid oral solution 6. Contents of the pack and other information 1. What Folic acid oral solution is and what it is used for This medicine is called Folic acid Colonis 1mg/ml Oral Solution (referred to in this leaflet as Folic acid oral solution). It contains folic acid (vitamin B9), which belongs to a group of vitamins called ‘B vitamins’. Each 1ml contains 1mg of folic acid. Folic acid oral solution is used for the prevention and treatment of conditions caused by deficiency of folic acid: 1. Prevention of neural tube defects (abnormalities of the spine, eg. spina bifida) in babies, including if you have previously had a baby with this disorder. 2. Prevention and treatment of anaemia caused by folic acid deficiency. This may occur in the following situations: ■ pregnancy ■ excessive alcohol intake or poor nutrition ■ effects of other drugs (eg. anticonvulsants, used to prevent fits) ■ sickle cell anaemia (or other types of anaemia caused by abnormal red blood cells) ■ problems with absorption of folic acid from the gut (e.g. tropical sprue or coeliac disease). 2. What you need to know before you take Folic acid oral solution DO NOT TAKE FOLIC ACID ORAL SOLUTION: ■ If you are allergic (hypersensitive) to folic acid or any o Read the complete document
OBJECT 1 FOLIC ACID COLONIS 1MG/ML ORAL SOLUTION Summary of Product Characteristics Updated 05-Jan-2018 | Colonis Pharma Ltd 1. Name of the medicinal product Folic acid Colonis 1 mg/ml oral solution 2. Qualitative and quantitative composition Each 1 ml of oral solution contains 1 mg of folic acid. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Oral solution Clear, yellow and odourless solution 4. Clinical particulars 4.1 Therapeutic indications 1. For the prophylaxis of neural tube defects in case of a positive history of previous neural tube defects (NTD). 2. For the prophylaxis of NTDs with no previous history of foetal neural tube defect and no other predisposing factors 3. For the treatment of folate deficiency: a. Folate deficient megaloblastic anaemia (in pregnancy, associated with alcoholism, drug intake such as anticonvulsants). For the prevention of megaloblastic anaemia, the cobalamin status should be established before initiation of folic acid therapy. b. Impaired utilization of folate i.e. use of concomitant drugs, in liver disease, inadequate intake (e.g. alcoholism, malnutrition etc.) c. Increased excretion of folate (e.g. alcoholism, haemolytic states). 4. Folate deficiency / megaloblastic anaemia associated with haemolytic anaemia (e.g. sickle cell anaemia) 5. Treatment of folate deficiency in malabsorption syndromes (parenteral administration of folic acid may need to be considered if oral treatment is not effective) (e.g.: tropical sprue. tropical sprue responds to folate supplements in the early stages of the disease but cobalamin status must also be checked, particularly later; coeliac disease in which case the necessity of supplementation with folate ceases once a gluten free diet is introduced; non-tropical sprue; in congenital folate malabsorption (oral treatment may not be effective and parental folate may therefore be required). Cobalamin status needs to be established in all megaloblastic states (not only in pregnancy). 4.2 Posology and method of administration Read the complete document